Barrier Therapeutics

Barrier Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization.

Barrier Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of a portfolio of innovative pharmaceutical products to address major medical needs in the field of dermatology. They currently have multiple product candidates based on intellectual property that they have licensed from third parties in clinical development, with four of these candidates in or entering Phase III clinical trials.